Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Insurers and self-funded employers are making significant changes to their GLP-1 drug coverage policies in 2025, reflecting the financial and operational challenges posed by the high-cost medications.

Omada Health, the virtual between-visit healthcare provider, today announced new results of an analysis that aimed to better understand weight maintenance following GLP-1 medication discontinuation ...

particularly given the low adherence rates and high cost of GLP-1s. To help employers, health plans, and pharmacy benefit managers deliver best-in-class outcomes with or without GLP-1 medications ...